Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT03745716. IPD Sharing: Not stated. Countries: 2. Publications: 0.
IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03175978. IPD Sharing: NO. Countries: 1. Publications: 0.
Belinostat in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00357162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
ClinicalTrials.gov study NCT00882102. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00384956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00382200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00830518. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01893372. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00968071. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BMS-986253 in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05148234. IPD Sharing: YES. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03151304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Req
ClinicalTrials.gov study NCT03900715. IPD Sharing: YES. Countries: 1. Publications: 0.
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01807091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01892371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00721214. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Trans
ClinicalTrials.gov study NCT00548847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01692197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT05209152. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
ClinicalTrials.gov study NCT00520468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00526292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.